Long-term outcome of catheter ablation of left fascicular ventricular arrhythmias

Ilaria My1, Fabian Moser2, Fabian W Loeck2

  • 1Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. ilariamy@libero.it.

Insights

Catheter ablation effectively treats ventricular arrhythmias (VAs) originating from the left ventricular conduction system, showing a 73% arrhythmia-free survival rate. This procedure is crucial for managing complex VAs involving the fascicles.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Optimal treatment for ventricular arrhythmias (VAs) involving the left ventricular conduction system is not well-defined due to low prevalence in Europe.
  • Limited data exists on the clinical characteristics and outcomes of catheter ablation for these specific VAs.

Purpose of the Study:

  • To describe the clinical and procedural aspects of catheter ablation for primary ventricular complexes (PVCs) and ventricular tachycardias (VTs) affecting the left ventricular conduction system.
  • To evaluate the long-term outcomes of European patients undergoing this specialized ablation procedure.

Main Methods:

  • Retrospective analysis of 27 Caucasian patients (2009-2022) undergoing electrophysiological study and catheter ablation.
  • Utilized transaortic and/or transseptal approaches for mapping and ablation.
  • Follow-up included Holter-ECGs, clinical evaluations, and the TRUST registry (NCT05521451).

Main Results:

  • VAs involved the left posterior fascicle (LPF) in 78%, left anterior fascicle (LAF) in 15%, and upper septum (US) in 7%.
  • Sustained VTs were more common with LPF involvement (57%), while PVCs/ns-VTs predominated with LAF involvement (75%).
  • Acute ablation success was 89%, with 73% arrhythmia-free survival at a median 30-month follow-up. Minor complications included fascicular blocks.

Conclusions:

  • Ventricular arrhythmias predominantly manifest as tachycardia involving the posterior fascicle and as PVCs involving the anterior fascicle.
  • Catheter ablation offers a favorable long-term clinical outcome for VAs originating from the left ventricular conduction system.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
207
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22